玉博生物

優(yōu)勢(shì)供應(yīng)，正品保證，*

全國：

美國派普泰克PeproTech  www.peprotech.com
     PeproTech China （派普泰克中國代表處） 是由美國PeproTech Inc.亞洲分公司在中國設(shè)立的外資常駐代表機(jī)構(gòu)，負(fù)責(zé)對(duì)細(xì)胞因子及相關(guān)產(chǎn)品（包括抗體和ELISA試劑盒等）進(jìn)行和市場(chǎng)推廣。
     PeproTech Inc. 創(chuàng)立于1988年，始終致力于為生命科學(xué)研究開發(fā)重組蛋白及相關(guān)產(chǎn)品，如今已成為能提供多種高質(zhì)量細(xì)胞因子和重組蛋白，相應(yīng)的單克隆、多克隆和生物素標(biāo)記抗體，以及ELISA試劑盒的世界*。PeproTech Inc.的產(chǎn)品涵蓋免疫調(diào)節(jié)蛋白、白介素、集落刺激因子、生長(zhǎng)因子、化學(xué)趨化因子、干擾素、脂聯(lián)素、成纖維生長(zhǎng)因子、轉(zhuǎn)化生長(zhǎng)因子、腫瘤壞死因子、神經(jīng)營養(yǎng)素和防御素等諸多生命科學(xué)研究領(lǐng)域中重要的生物活性分子。為跟蹤當(dāng)今科研發(fā)展、滿足日益增長(zhǎng)的需求，PeproTech Inc.研制出無動(dòng)物成分的重組蛋白（animal-free recombinant proteins）。這些蛋白是利用專有的無動(dòng)物成分生產(chǎn)設(shè)施，在嚴(yán)格的無動(dòng)物成分條件下生產(chǎn)出來，因此痕量的動(dòng)物源性污染引發(fā)潛在問題的可能性被降至zui低，從而*達(dá)到臨床前研究和細(xì)胞治療用標(biāo)準(zhǔn)。此外，PeproTech Inc.還開發(fā)出無動(dòng)物成分的培養(yǎng)基添加物試劑盒（animal-free Media Supplement Kits）。這些試劑盒經(jīng)改良設(shè)計(jì)，其中的無血清組分對(duì)多種哺乳動(dòng)物細(xì)胞的生長(zhǎng)有更好的維持能力。 PeproTech Inc.的產(chǎn)品自2000年進(jìn)入中國市場(chǎng)以來，以其優(yōu)良的品質(zhì)和合理的價(jià)格迅速得到國內(nèi)各重點(diǎn)研究和實(shí)驗(yàn)機(jī)構(gòu)的認(rèn)可和青睞。鑒于中國經(jīng)濟(jì)發(fā)展的良好態(tài)勢(shì)和中國生物醫(yī)藥研發(fā)投入的巨額增長(zhǎng)，PeproTech Inc.于2009年10月在中國蘇州設(shè)立代表機(jī)構(gòu)，意為中國的廣大用戶提供更好的支持和服務(wù)，并助中國的科研和產(chǎn)業(yè)開發(fā)一臂之力。

PeproTech位于美國，成立于1988年，公司已開發(fā)了200種以上的重組細(xì)胞因子和相關(guān)抗體。所有產(chǎn)品以凍干形式提供，以方便運(yùn)輸和儲(chǔ)存。目前公司正在擴(kuò)大產(chǎn)品線，生產(chǎn)抗原親和多抗及其生物素標(biāo)記物，ELISA試劑盒和新型抗體。

產(chǎn)品分類：
Human Growth Factors & Cytokines
Human, Murine & Rat Chemokines
Murine & Rat Growth Factors & Cytokines
Human & Rat Neurotrophins
Other Recombinant Proteins
Monoclonal Antibodies
Antigen-Affinity Purified Polyclonal Antibodies
Biotinylated Polyclonal Antibodies
ELISA Development Kits

PeproTech was established in 1988 by a group of scientists who decided to focus their efforts on the development and production of recombinant cytokines for life-science research. Today, PeproTech is a world leader in supplying high quality cytokine products including E. coli, insect, and mammalian cell-derived recombinant proteins, their monoclonal/polyclonal antibodies, ELISA development kits, and other cytokine-related reagents. These products are distributed worldwide through customer-service offices in the US, UK, France, Germany, Israel, Korea, China, Japan, Brazil, and Mexico. We plan to maintain the highly competitive price of our products and to expand their distribution to Australia, New Zealand, and other locations. To keep up with current research and growing demand we have recently expanded our production capabilities to include a 5000 sq. ft. animal-free manufacturing facility. A key component in keeping up with current scientific advancements has been our collaboration with researchers in both academia and industry who provide us with suggestions necessary to continuously expand our product pipeline. We encourage you to convey to us your particular research needs and promise to do our best to fulfill them.